Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tissue hypoxia response pathways encompass a group of highly conserved cellular mechanisms that detect and respond to low oxygen availability. Central to this process are hypoxia-inducible factors (HIFs), which are transcription factor complexes that regulate the expression of hundreds of genes involved in adaptation to hypoxia, including those governing angiogenesis, metabolism, cell survival, and immune regulation. The response involves complex signaling networks (HIF pathway, unfolded protein response, mTOR signaling, and others) that alter cell behavior in physiological and pathological contexts, such as development, cancer, inflammation, cardiovascular, and pulmonary diseases. Modulation of these pathways—particularly through selective inhibition or activation of components like HIF-1α or HIF-2α—is a current therapeutic strategy in conditions ranging from anemia to cancer
Inhibition of HIF prolyl hydroxylases (preventing HIF degradation, increasing HIF activity); Inhibition of HIF-2α dimerization (reducing HIF-2-mediated gene transcription)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxia-inducible factor (HIF) pathway (HIF pathway).